Cognition Therapeutics, Inc. (CGTX) Ownership
CGTX ownership summary
as of October 18, 2026- Institutions
- 23.8% of shares outstanding
- Insiders
- 1.29% of shares outstanding
- Shares outstanding
- 95.1M
- Float
- 87.5M shares available to trade
- Short interest
- 8.60% 7.6M shares short
- Days to cover
- 18.88 short interest down 2.1% vs prior month
- Institutions 23.75%
- Insiders 1.29%
- Other investors 74.96%
CGTX top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BIOS CAPITAL MANAGEMENT, LP | 6.31% | 6.0M | $4.4M | — | June 30, 2026 |
| 2 | Davenport & Company LLC | 4.48% | 4.3M | $3.1M | +1.4M (+47.2%) | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 3.62% | 3.4M | $2.5M | +436,988 (+14.6%) | June 30, 2026 |
| 4 | BlackRock Inc | 1.33% | 1.3M | $921,255 | +293,631 (+30.3%) | June 30, 2026 |
| 5 | Chescapmanager LLC | 1.05% | 997K | $727,831 | — | June 30, 2026 |
| 6 | Geode Capital Management, LLC | 0.96% | 910K | $664,304 | −10,202 (−1.1%) | June 30, 2026 |
| 7 | Renaissance Technologies Corp | 0.73% | 693K | $506,100 | −423,848 (−37.9%) | June 30, 2026 |
| 8 | Hilton Capital Management, LLC | 0.58% | 549K | $400,734 | — | June 30, 2026 |
| 9 | Vanguard Fiduciary Trust Co | 0.53% | 508K | $371,001 | +44,536 (+9.6%) | June 30, 2026 |
| 10 | CM Management, LLC | 0.47% | 450K | $328,500 | +50,000 (+12.5%) | June 30, 2026 |
| 11 | Dauntless Investment Group, LLC | 0.39% | 372K | $271,342 | −59,299 (−13.8%) | June 30, 2026 |
| 12 | Sigma Planning Corp | 0.38% | 362K | $264,453 | +24,500 (+7.3%) | June 30, 2026 |
| 13 | State Street Corp | 0.37% | 349K | $254,758 | +34,500 (+11.0%) | June 30, 2026 |
| 14 | Tocqueville Asset Management L.P. | 0.34% | 320K | $233,965 | +125,500 (+64.4%) | June 30, 2026 |
| 15 | UBS Group AG | 0.23% | 219K | $159,531 | +141,663 (+184.3%) | June 30, 2026 |
| 16 | American Financial Group Inc | 0.22% | 205K | $149,650 | — | June 30, 2026 |
| 17 | Northern Trust Corp | 0.19% | 178K | $130,087 | +9,516 (+5.6%) | June 30, 2026 |
| 18 | Voss Capital LLC | 0.18% | 175K | $127,750 | −25,000 (−12.5%) | June 30, 2026 |
| 19 | Texas Capital Bank Wealth Management Services Inc | 0.15% | 143K | $104,606 | +20,000 (+16.2%) | June 30, 2026 |
| 20 | Charles Schwab Investment Management Inc | 0.09% | 85K | $62,006 | — | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 2.5M shares and 4 cut 518K.
CGTX top mutual fund and ETF holders
13 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.57% | 2.4M | $1.8M | — | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.45% | 432K | $315,113 | +12,777 (+3.1%) | August 31, 2026 |
| 3 | iShares Micro-Cap ETF | 0.28% | 263K | $191,667 | −1,811 (−0.7%) | September 30, 2026 |
| 4 | Fidelity Total Market Index | 0.15% | 144K | $104,870 | — | August 31, 2026 |
| 5 | Fidelity Series Total Market Index | 0.12% | 119K | $86,652 | — | August 31, 2026 |
| 6 | Schwab Total Stock Market Index | 0.09% | 85K | $62,006 | — | August 31, 2026 |
| 7 | Vanguard Balanced Index Inv | 0.04% | 39K | $28,313 | — | August 31, 2026 |
| 8 | Vanguard MStar Inst Ttl StkMktIdxInstlPl | 0.03% | 32K | $23,212 | — | August 31, 2026 |
| 9 | Gabelli Global Mini Mites I | 0.03% | 30K | $21,900 | — | June 30, 2026 |
| 10 | Vanguard U.S. Eq Idx £ Acc | 0.02% | 24K | $17,258 | — | August 31, 2026 |
| 11 | 1290 VT Micro Cap K | 0.02% | 18K | $13,429 | — | August 31, 2026 |
| 12 | iShares Neuroscience and Healthcare ETF | 0.01% | 8,501 | $6,206 | — | September 30, 2026 |
| 13 | Fidelity Nasdaq Composite Index | 0.01% | 5,757 | $4,203 | −45,297 (−88.7%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
CGTX insider transactions
latest 2| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-16 | John Brendan Doyle | Buy | $1.13 | 10,000 | $11,300 |
| 2026-04-16 | Lisa Ricciardi | Buy | $1.10 | 9,175 | $10,092 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
CGTX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns CGTX
Institutional investors own 23.8% of Cognition Therapeutics's shares and insiders 1.29%. The largest holder is BIOS CAPITAL MANAGEMENT, LP with 6.31% of the shares (6.0M), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 4 reduced their stake in the latest filings. Short interest is 8.60% of the float, or 18.88 days of average trading volume. The share count rose 324.3% since 2020.
Related: CGTX analyst forecast, CGTX key metrics. See the CGTX stock overview for the latest quote and news.
CGTX ownership FAQ
Who owns the most Cognition Therapeutics stock?
The largest shareholders of Cognition Therapeutics are BIOS CAPITAL MANAGEMENT, LP (6.31%), Davenport & Company LLC (4.48%), Vanguard Capital Management, LLC (3.62%), BlackRock Inc (1.33%), Chescapmanager LLC (1.05%).
What percentage of Cognition Therapeutics is owned by institutions?
Institutions hold 23.8% of Cognition Therapeutics's shares outstanding; insiders hold 1.29%.
Which funds own Cognition Therapeutics?
The largest fund holders of Cognition Therapeutics are Vanguard MStar Total Stk Mkt Idx Invest (2.57%), Fidelity Extended Market Index (0.45%), iShares Micro-Cap ETF (0.28%), Fidelity Total Market Index (0.15%), Fidelity Series Total Market Index (0.12%).
What is Cognition Therapeutics's short interest?
7.6M shares of Cognition Therapeutics were sold short, 8.60% of the float; at the average daily volume it would take 18.88 days to cover.
Are insiders buying or selling Cognition Therapeutics?
Of the latest 2 reported insider transactions in Cognition Therapeutics (since April 16, 2026), 2 were purchases and 0 were sales.
How many shares of Cognition Therapeutics are outstanding?
Cognition Therapeutics has 95.1M shares outstanding, of which 87.5M are in the public float.